Market Overview

Mornings Movers for Feb. 27, 2014: PEIX, JCP, SYMX, CIE, SHLD, BBY Higher, INO, NDLS, HK, CY, DYAX Lower

Share:

Moving up:

  • Pacific Ethanol (NASDAQ: PEIX) - up 29% - reports Q4 EPS of $0.54 vs $(0.04) analyst estimates. Revenue came in at $215.30M.
  • JC Penney (NYSE: JCP) - up 22% - EPS of $0.11 vs $(0.76) Est; Revenue of $3.78B vs $3.94B Est; Upgraded by Wells Fargo from Underperform to Market Perform.
  • Synthesis Energy (NASDAQ: SYMX) - up 20% - Premarket on Twitter Mention of Possible GE Cooperation.
  • Cobalt International Energy (NYSE: CIE) - up 9.5% - Reports Q4 loss of $0.21 per share, excluding non-recurring items versus analyst estimates of ($0.15).
  • Cell Therapeutics (NASDAQ: CTIC) - up 8.2% - NICE publishes final guidance on PIXUVRI (pixantrone) as a cost-effective monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
  • Cardica (NASDAQ: CRDC) - up 8% - Receives FDA 510(k) Clearance for Both MicroCutter XCHANGE™ 30 White Cartridge And New Material.
  • Sears (NASDAQ: SHLD) - up 7.5% - Reports Q4 EPS of $(3.37) vs $(1.14) Est; Revenue of $10.59B vs $9.0B Est.
  • Best Buy (NYSE: BBY) - up 7.2% - Reports Q4 EPS of $1.24 vs $1.01 Est; Revenue of $14.50B vs $14.66B Est.
  • Solazyme (NASDAQ: SZYM) - up 6% - Reports Q4 EPS of $(0.49) vs $(0.39) Est; Revenue of $11.30M vs $12.11M Est.
  • Workday (NYSE: WDAY) - up 5.5% - Reports Q4 EPS of $(0.32) vs $(0.16) Est; Revenue of $141.90M vs $137.91M Est.
  • Cimatron (NASDAQ: CIMT) - up 3.5% - Reports revenue of $12.7M vs $12.6M estimates; Reported EPS of $0.16, missing analyst estimates of $0.18.

Moving down:

  • Inovio Pharmaceuticals (NYSE: INO) - down 12% - Announces Public Offering of Common Stock; Size Not Mentioned.
  • Noodles & Company (NASDAQ: NDLS) - down 6.5% - Reports Q4 EPS of $0.11 vs $0.12 Est; Revenue of $91.5M vs $92.5M Est.
  • Halcon Resources (NYSE: HK) - down 5.7% - Reports Q4 EPS of $0.01 vs $0.04 Est; Revenue of $289.30M vs $290.09M Est.
  • Cypress Semiconductor (NASDAQ: CY) - down 4.5% - Downgraded by Pacific Crest from Outperform to Sector Perform and removes the price target of $11.
  • Dyax Corp (NASDAQ: DYAX) - down 2.8% - Leerink Swann Downgrades Dyax Corp. to Market Perform, Maintains $12.00 PT.
  • Exact Sciences (NASDAQ: EXAS) - down 2.5% - Will present its case before an FDA panel of experts on March 27; Cologuard CRC test is expected to be cleared by the FDA this year (via Seeking Alpha).
  • Wabash National (NYSE: WNC) - down 2.5% - Morgan Stanley Initiates Coverage on Wabash National Corporation at Underweight.
  • Walter Investment Management (NYSE: WAC) - down 2.5% - Reports Q4 EPS of $1.07 vs $1.24 Est; Revenue of $402.80M vs $396.22M Est. Lowers FY2014 EPS Guidance from $6.00-6.50 to $5.25-6.25 vs $5.82 Est.
  • BioScrip (NASDAQ: BIOS) - down 2.5% - Reports Q4 EPS of $(0.23) vs $0.02 Est; Revenue of $243.50M vs $237.58M Est.
  • Zogenix (NASDAQ: ZGNX) - down 1.5% - Pressure grows on FDA to revoke approval of Zogenix's Zohydro (via Seeking Alpha)
 

Related Articles (PEIX + JCP)

View Comments and Join the Discussion!

Posted-In: News Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com